Kanpur: The Indian Institute of Technology Kanpur (IIT-K) has signed a Memorandum of Understanding (MOU) with Conlis Global Inc for licensing of an innovative new technology to promote bone healing and regeneration. Conlis Global Inc is a biotechnology company based in Canada.
The technology— ‘Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds for Bioactive Molecule Delivery in Musculoskeletal Regeneration’ has been developed by Prof Ashok Kumar and his team from the department of biological sciences & bioengineering at IIT-Kanpur.
The MoU was signed by dean of resources and development IIT-Kanpur prof Tarun Gupta, and CEO, Conlis Global Inc Dr Sumrita Bhat at IIT-K in the presence of director, IIT-Kanpur prof S Ganesh, professor in-charge prof Ankush Sharma, Start-up Incubation and Innovation Centre (SIIC), IIT-K, department of biological sciences & bioengineering, IIT-K Prof Ashok Kumar and chief technology officer, Conlis Global Inc Dr Raman Koul.
Highlighting the importance of this MoU, Prof Ganesh said, “The licensing of this novel technology developed in-house that promotes bone healing and regeneration to Conlis Global is yet another significant milestone in the R&D endeavour of the institute. It is a testament to the high quality of research at IIT-K that brings real and practical benefits to people. I congratulate Prof Ashok Kumar and his team”.
Dr Bhat of Conlis Global Inc expressed enthusiasm about the potential impact of this technology, “We are thrilled to partner with IIT-Kanpur to bring this innovative solution to the market. It represents a significant step forward in treating bone and joint disorders, and we look forward to taking this to market to benefit patients worldwide.”
Prof Tarun Gupta said, “The MoU is an important landmark in our efforts to build a bridge between research & development and taking a product from the lab to the commercial stage and into the market. This will inspire us to continue to work on supporting research in various domains and helping our engineers, scientists and other talents to bring their dreams into fruition.”
Prof Ashok Kumar said, “The technology facilitates bone regeneration in a biocompatible manner by acting as a carrier for bone-active biomolecules, delivering them directly to the site of an implant. The material is a promising approach for reconstructing and repairing bone defects while addressing the drawbacks and complications associated with technologies that are available in the market at present.” The novel Nano Hydroxyapatite based Porous Composite Scaffolds is biodegradable and has osteoinductive (bone healing process) and osteopromotive (material for new bone growth) properties for bone regeneration. They are highly biocompatible resulting in good cell material interaction with osteoblast cells (cells responsible for mineralization of bone during bone formation and bone remodelling), exhibiting a high mechanical strength and interaction between the polymer network and the solvent.
These functionalized scaffolds can be used as fillers in large size bone defects, without compromising the connectivity and structural defects, oxygen and blood circulation thereby enhancing tissue formation, mineralization, and rapid defect healing. It can also be used as bone substitute, overcoming autograft limitations.
The technology— ‘Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds for Bioactive Molecule Delivery in Musculoskeletal Regeneration’ has been developed by Prof Ashok Kumar and his team from the department of biological sciences & bioengineering at IIT-Kanpur.
The MoU was signed by dean of resources and development IIT-Kanpur prof Tarun Gupta, and CEO, Conlis Global Inc Dr Sumrita Bhat at IIT-K in the presence of director, IIT-Kanpur prof S Ganesh, professor in-charge prof Ankush Sharma, Start-up Incubation and Innovation Centre (SIIC), IIT-K, department of biological sciences & bioengineering, IIT-K Prof Ashok Kumar and chief technology officer, Conlis Global Inc Dr Raman Koul.
Highlighting the importance of this MoU, Prof Ganesh said, “The licensing of this novel technology developed in-house that promotes bone healing and regeneration to Conlis Global is yet another significant milestone in the R&D endeavour of the institute. It is a testament to the high quality of research at IIT-K that brings real and practical benefits to people. I congratulate Prof Ashok Kumar and his team”.
Dr Bhat of Conlis Global Inc expressed enthusiasm about the potential impact of this technology, “We are thrilled to partner with IIT-Kanpur to bring this innovative solution to the market. It represents a significant step forward in treating bone and joint disorders, and we look forward to taking this to market to benefit patients worldwide.”
Prof Tarun Gupta said, “The MoU is an important landmark in our efforts to build a bridge between research & development and taking a product from the lab to the commercial stage and into the market. This will inspire us to continue to work on supporting research in various domains and helping our engineers, scientists and other talents to bring their dreams into fruition.”
Prof Ashok Kumar said, “The technology facilitates bone regeneration in a biocompatible manner by acting as a carrier for bone-active biomolecules, delivering them directly to the site of an implant. The material is a promising approach for reconstructing and repairing bone defects while addressing the drawbacks and complications associated with technologies that are available in the market at present.” The novel Nano Hydroxyapatite based Porous Composite Scaffolds is biodegradable and has osteoinductive (bone healing process) and osteopromotive (material for new bone growth) properties for bone regeneration. They are highly biocompatible resulting in good cell material interaction with osteoblast cells (cells responsible for mineralization of bone during bone formation and bone remodelling), exhibiting a high mechanical strength and interaction between the polymer network and the solvent.
These functionalized scaffolds can be used as fillers in large size bone defects, without compromising the connectivity and structural defects, oxygen and blood circulation thereby enhancing tissue formation, mineralization, and rapid defect healing. It can also be used as bone substitute, overcoming autograft limitations.